Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- Registers
- 1
- Registrations
- 7
- With their own page
- 7
- Companies
- 2
All medicines with Anhydrous
Human medicines from every register that match Anhydrous by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
449 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Monobasic Sodium Phosphate and Dibasic Sodium PhosphateCombination | United States | 0.398GM; 1.102GM | tablet | Marketed | Novel Labs INC |
| OsmoprepCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| VisicolCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric AcidCombination | United States | 12GM/PACKET; 3.5GM/PACKET; 10MG/PACKET | for solution | Marketed | Hetero Labs LTD V |
| Anhydron | United States | 2MG | tablet | Not marketed | Lilly |
| Novrad | United States | 50MG BASE/5ML | suspension | Not marketed | Lilly |
| Novrad | United States | 100MG BASE, 50MG BASE | capsule | Not marketed | Lilly |
| Peg 3350 and ElectrolytesCombination | United States | 3350 236GM/BOT; 2.97GM/BOT; 6.74GM/BOT; 5.86GM/BOT; 22.74GM/BOT, 3350 240GM/BOT; 2.98GM/BOT; 6.72GM/BOT; 5.84GM/BOT; 22.72GM/BOT | for solution | Marketed | Extrovis |
| Polyethylene Glycol 3350 and ElectrolytesCombination | United States | 3350 236GM/BOT; 2.97GM/BOT; 6.74GM/BOT; 5.86GM/BOT; 22.74GM/BOT, 3350 240GM/BOT; 2.98GM/BOT; 6.72GM/BOT; 5.84GM/BOT; 22.72GM/BOT | for solution | Marketed | Paddock LLC |
| Ionosol MB and Dextrose 5% in Plastic ContainerCombination | United States | 5GM/100ML; 30MG/100ML; 141MG/100ML; 15MG/100ML; 260MG/100ML; 25MG/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Amversio | European Union | Authorised | Serb SA | ||
| GolytelyCombination | United States | 3350 227.1GM/PACKET; 2.82GM/PACKET; 6.36GM/PACKET; 5.53GM/PACKET; 21.5GM/PACKET, 3350 236GM/BOT; 2.97GM/BOT; 6.74GM/BOT; 5.86GM/BOT; 22.74GM/BOT | for solution | Marketed | Azurity |
| Cystadane | European Union | Authorised | Recordati Rare Diseases | ||
| Sprycel | European Union | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| Avagard CHGCombination | Canada | 61 % / W/W + 1 % / W/W | Lotion | Marketed | Solventum Canada Limited |
| Fuzaton Anticold SolutionCombination | Taiwan | 內服液劑 | Authorised | 賜利優醫藥生技有限公司 | |
| Potassium Chloride 0.3% w/v and Glucose 5% w/v Intravenous Infusion BPCombination | Singapore | 50.0g/1000ml + 3.0g/1000ml | infusion, solution | Authorised | B. Braun Singapore Pte LTD |
| Potassium Chloride 0.15% w/v and Glucose 5% w/v Intravenous Infusion BPCombination | Singapore | 50.0g/1000ml + 1.5g/1000ml | infusion, solution | Authorised | B. Braun Singapore Pte LTD |
| Pabron Extra Analgesic TabletsCombination | Taiwan | 錠劑 | Authorised | 台灣大正製藥股份有限公司 | |
| MoviprepCombination | Canada | 4.7 G / SACHET + 100 G / SACHET + 1.015 G / SACHET + 5.9 G / SACHET + 2.691 G / SACHET + 7.5 G / SACHET | Powder For Solution | Marketed | Aralez Pharmaceuticals Canada INC |
| Prismasol 4Combination | Canada | 5.145 G / L + 22 G / L + 5.4 G / L + 2.033 G / L + 0.314 G / L + 3.09 G / L + 6.45 G / L | Solution | Marketed | Vantive Ulc |
| Zoledronic Acid Fresenius Kabi Concentrate for Solution for Infusion 4MG/5ML | Singapore | 4mg/5ml | infusion, solution concentrate | Authorised | Fresenius Kabi (Singapore) Pte LTD |
| Dextrose 5% and Sodium Chloride 0.9% Injection USPCombination | Singapore | 5 g/100 ml + 0.9 g/100 ml | injection | Authorised | Baxter Healthcare (Asia) Pte LTD |
| Dextrose 5% and Sodium Chloride 0.45% Injection USPCombination | Singapore | 5 g/100 ml + 450 mg/100 ml | injection | Authorised | Baxter Healthcare (Asia) Pte LTD |
| Xylestesin-A InjectionCombination | Singapore | 0.0125 mg/ml + 20 mg/ml | injection | Authorised | Joyson Pte. LTD. |